Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0145
0.00 (0.00%)
Mar 13, 2026, 9:30 AM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $1.02 million as of March 16, 2026. Its market cap has decreased by -82.56% in one year.
Market Cap
1.02M
Enterprise Value
32.41M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 1.02M, a decrease of -99.71%. That is a compound annual growth rate of -58.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 1.02M | 22.58% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neon Bloom | 1.40M |
| Exousia Pro | 1.26M |
| Evofem Biosciences | 1.15M |
| Halberd | 1.12M |
| CERo Therapeutics Holdings | 1.10M |
| Eastgate Biotech | 1.06M |
| Protagenic Therapeutics | 887.18K |
| EV Biologics | 848.71K |